Cancer Causes & Control

, Volume 20, Issue 5, pp 751–756

Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care

  • Maria Paula Curado
  • Lydia Voti
  • Ana Maria Sortino-Rachou
Original Paper

Abstract

Cancer registration data plays a major role in the design and monitoring of cancer control activities and policies, and population-based cancer registries (PBCR) are the main source of information. In developed countries, the healthcare infrastructure enables the registration of quality cancer data. In low and middle Income countries (LMIC), where health care facilities are limited or scarce, cancer registration data may be of low quality. The aim of this article is to demonstrate the value of cancer incidence data for LMIC, even when quality is questionable, as well as to attempt to interpret the messages that the quality indicators convey both for cancer registration and the healthcare system. The study of data submitted to the Cancer incidence in five continents, volume nine (CI5-IX) leads to the conclusion that when PBCR from LMIC cannot provide good quality data it may indicate a deficiency that goes above and beyond the registrar ability. The quality control indicators evaluated provide insight on local conditions for cancer diagnosis and care. Low data quality not only signals lack of collaboration among reporting sources and the inability of the registrar to perform quality abstracting, but also points to specific weaknesses of the cancer care system and can guide improvement goals and efforts.

Keywords

Epidemiology Incidence studies Cancer Low income population Registries 

References

  1. 1.
    Parkin DM (2006) The evolution of the population-based cancer registry. Nat Rev Cancer 6(8):603–612. doi:10.1038/nrc1948 PubMedCrossRefGoogle Scholar
  2. 2.
    Curado MP, Edwards B, Shin HR, Strom H, Ferlay J, Heanue M et al (2007) Cancer incidence in five continents—Volume IX. IARC 2007 November 28. Available from URL http://www-dep.iarc.fr
  3. 3.
    Bah E, Parkin DM, Hall AJ, Jack AD, Whittle H (2001) Cancer in the Gambia: 1988–97. Br J Cancer 84(9):1207–1214. doi:10.1054/bjoc.2001.1730 PubMedCrossRefGoogle Scholar
  4. 4.
    Surveillance, Epidemiology and End Results (SEER) (2008) National Cancer Institute. Available from URL http://seer.cancer.gov/
  5. 5.
    Valsecchi MG, Steliarova-Foucher E (2008) Cancer registration in developing countries: luxury or necessity? Lancet Oncol 9(2):159–167. doi:10.1016/S1470-2045(08)70028-7 FebruaryPubMedCrossRefGoogle Scholar
  6. 6.
    Muir CS, Percy C (1991) Cancer registration: principles and methods. Classification and coding of neoplasms. IARC Sci Publ 95:64–81Google Scholar
  7. 7.
    Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5 version 2.0 2004. Available from URL http://www-dep.iarc.fr/
  8. 8.
    Working Group of the International Association of Cancer Registries (2005) Guidelines on confidentiality for population-based cancer registration. Eur J Cancer Prev 144:309–327. doi:10.1097/00008469-200508000-00003 Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Maria Paula Curado
    • 1
  • Lydia Voti
    • 1
  • Ana Maria Sortino-Rachou
    • 2
  1. 1.Descriptive Epidemiology Production Group, Biostatistics and Epidemiology ClusterInternational Agency for Research on Cancer (IARC)Lyon Cedex 08France
  2. 2.Hospital 9 de JulhoSao PauloBrazil

Personalised recommendations